

Is Everolimus still in shortage in 2026? Get the latest update on Afinitor and generic Everolimus availability, costs, and what patients can do.
If you rely on Everolimus — whether it's Afinitor for cancer treatment or Zortress for transplant rejection — you've probably experienced the frustration of hearing "we don't have that in stock" at least once. Everolimus supply has been unpredictable in recent years, and many patients are still dealing with availability challenges in 2026.
This article gives you an honest, up-to-date look at the Everolimus shortage situation: what's happening, why it's happening, what it costs, and what you can do about it.
Everolimus has not been in a continuous, nationwide shortage, but it has experienced intermittent supply disruptions that affect specific strengths and formulations. In 2026, the situation looks like this:
The FDA's drug shortage database may list specific Everolimus products as having limited availability. Check with your pharmacy or use Medfinder for the most current stock information in your area.
Several factors contribute to the ongoing availability challenges:
Everolimus is a complex molecule that requires specialized manufacturing processes. Any disruption — equipment issues, raw material shortages, or regulatory compliance matters — can reduce output for weeks or months.
Unlike common medications that are distributed to thousands of retail pharmacies, Everolimus moves through a more limited specialty pharmacy network. This means fewer locations stock it, and when demand spikes in a region, local supply can dry up quickly.
Prior authorization requirements and specialty pharmacy mandates can create bottlenecks. Even when the drug is physically available, administrative delays can make it feel like a shortage from the patient's perspective.
For a deeper explanation, read why Everolimus is so hard to find in 2026.
Everolimus is an expensive medication. Here's what you can expect:
Most patients don't pay the full cash price. Insurance, manufacturer copay programs, and patient assistance foundations can dramatically reduce your out-of-pocket costs. Learn more in our guide on how to save money on Everolimus.
The availability of generic Everolimus has been the most significant positive development in recent years. Multiple manufacturers now produce generic versions, which has:
Additionally, the ongoing development of new targeted therapies means that for some conditions, doctors have more treatment options than ever before. If you're interested in alternatives, check out our article on alternatives to Everolimus.
Here are the most effective steps you can take right now:
For detailed tips, read our full guide on how to find Everolimus in stock near you.
The Everolimus supply situation in 2026 isn't a crisis, but it's far from smooth. Intermittent disruptions, specialty pharmacy requirements, and high costs continue to make this medication harder to access than it should be.
The best thing you can do is stay informed, plan ahead, and use every resource available — from Medfinder for stock checks to patient assistance programs for financial help. Your care team is your best ally in navigating these challenges, so don't hesitate to reach out to them when you need help.
For information about side effects and what to watch for, visit our guide on Everolimus side effects.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.